Corrigendum: Genetic diagnosis of Duchenne/Becker muscular dystrophy using next-generation sequencing: Validation analysis of DMD mutations (Journal of Human Genetics (2016) 61 (483-489) DOI: 10.1038/jhg.2016.7);Genetic diagnosis of Duchenne/Becker muscular dystrophy using next-generation sequencing: Validation analysis of DMD mutations

Journal of Human Genetics

Volumn 61, Issue 6, 2016, Pages 483-489

  Okubo, Mariko ^a,b   Minami, Narihiro ^a,b   Goto, Kanako ^a,b   Goto, Yuichi ^b   Noguchi, Satoru ^a   Mitsuhashi, Satomi ^a,b   Nishino, Ichizo ^a,b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ARTICLE; BECKER MUSCULAR DYSTROPHY; COHORT ANALYSIS; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENETIC ANALYZER; GENETIC SCREENING; HIGH THROUGHPUT SEQUENCING; HISTOPATHOLOGY; HUMAN; ION PGM SEQUENCER; ION TORRENT SEQUENCER; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEXT GENERATION SEQUENCING; NONSENSE MUTATION; POINT MUTATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; AMINO ACID SUBSTITUTION; CASE CONTROL STUDY; EXON; GENE DOSAGE; GENETICS; GENOTYPE; INTRON; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION;

ALLELES; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DYSTROPHIN; EXONS; GENE DOSAGE; GENE DUPLICATION; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INTRONS; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; SEQUENCE DELETION;

EID: 84976553960     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2017.54     Document Type: Erratum

References (16)

1. Emery, A. E. Population frequencies of inherited neuromuscular disease-a world survey. Neuromuscl. Disord. 1, 19-29 (1991).
2. Bushby, K., Finkel, R., Brinkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L. et al. Diagnosis and management of Duchenne muscular dystrophy, part1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9, 77-93 (2010).
3. Ahn, A. H. & Kunkel, L. M. The structural and functional diversity of dystrophin. Nat. Genet. 3, 283-291 (1993).
4. Takeshima, Y., Yagi, M., Okizuka, Y., Awano, H., Zhang, Z., Yamauchi, Y. et al. Mutation spectrum of dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. J. Hum. Genet. 55, 379-388 (2010).
5. Magri, F., Govoni, A., Angelo, M. G., Del Bo, R., Gbezzi, S., Sandra, G. et al. Genetype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J. Neurol. 258, 1610-1623 (2011).
6. Mah, J. K., Selby, K., Campbell, C., Nadeau, A., Tarnopolsky, M., McCormicj, A. et al. A Population-Based Study of Dystrophin Mutation in Canada. Can. J. Neurol. Sci. 38, 465-474 (2011).
7. Lalic, T., Vossen, R. H., Coffa, J., Schouten, J. P., Guc-Scekic, M., Radivojevic, D. et al. Deletion and duplication screening in the DMD gene using MLPA. Eur. J. Hum. Genet. 13, 1231-1234 (2005).
8. Flanigan, K. M., Dunn, D. M., Niederhausem, A. V., Soltanzadeh, P., Gappmarie, E., Howard, M. T. et al. Mutational spectrum of dmd mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum. Mutat. 30, 1657-1666 (2009).
9. MaliK, V., Rodino-Klapac, L. R., Viollet, L., Wall, C., King, W., Al-Dahhak, R. et al. Gentamicin-Induced readthrough of stop codons in duchenne muscular dystrophy. Ann. Neurol. 67, 771-780 (2010).
10. Welch, E. M., Barton, E. R., Zhuo, J. Tomizawa, Y., Friesen, W. J., Trifillis, P. et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 447, 87-93 (2007).
11. Finkel, R. S., Flanigan, K. M., Wong, B., Bonnemann, C., Sampson, K., Sweeney, H. L. et al. Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation duchenne muscular dystrophy. PLoS ONE 8, e81302 (2013).
12. Falzarano, M. S., Scotton, C., Passarelli, C. &, Ferlini, A. Duchenne muscular dystrophy: from diagnosis to therapy. Molecules 28, 18168-18184 (2015).
13. Lim, B. C., Lee, S., Shin, J. Y., Kim, J. I., Hwang, H., Kim, K. J. et al. Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a signal platform. J. Med. Genet. 48, 731-736 (2011).
14. Wei, X., Dai, Y., Yu, P., Qu, N., Lan, Z., Hong, X. et al. Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD: a multi-population diagnostic study. Eur. J. Hum. Genet. 22, 110-118 (2014).
15. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
16. Janssen, B., Hartmann, C., Scholz, V., Jauch, A. & Zschocke, J. MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfall. Neurogenetics 6, 29-35 (2005).